| MOPEA05 | IL7RA single nucleotide polymorphisms and CMV co-infection associate with MAIT cell dysregulation in treated HIV-1 infection | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| MOPEA07 | Novel adjuvant ALFQ elicits a strong immune stimulatory signature that correlates with remarkable magnitude T cell and humoral immune responses following pox-protein vaccination | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| MOPEA08 | GITR is expressed on HIV-specific CD8+T-cells from people living with HIV (PLWH) and its ex vivo triggering enhances cell functionality: a possible target for immune reprogramming | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| MOPEA09 | Patient-derived envelope sequences are differentially resistant to SERINC5-mediated restriction of HIV-1 infectivity | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| MOPEA10 | Structure and Immunogenicity of native-like HIV-1 Clade-C envelope trimers from a pediatric elite-neutralizer across diverse platforms | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| MOPEA11 | Longitudinal profiling of immune responses to simian immunodeficiency virus throughout disease progression and antiretroviral treatment | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| OAA0402 | Novel V1 deleted-envelope vaccine based on VLP protects against SHIV infection | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0403 | Perturbation of mucosal granulocytic effector cells in lentivirus infections | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0404 | Diverse envelope trimers with altered glycan coverage around the CD4-binding site elicit neutralizing antibodies of >50% breadth in NHPs | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OALBX0104 | Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |